PHOENIX, October 23, 2014 /PRNewswire/ -- Insiderslab.com, a U.S. market research community with a special focus on updating investors with insider trading news, revealed the latest insider trading alerts for U.S. stock investors, who can access these reports through the links below, including stock performance, insider trading signals, and visual results. The reports cover the stocks of Yahoo! (NASDAQ:YHOO), 3D Systems (NYSE:DDD), Regulus Therapeutics (NASDAQ:RGLS), Huntington Bancshares (NASDAQ:HBAN), Cree (NASDAQ:CREE), and Advanced Micro Devices (NYSE:AMD).
(Read the full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Report Highlights:
Yahoo! Inc. (NASDAQ:YHOO): By the end of last trading session, the shares of Yahoo! (NASDAQ:YHOO) rose 4.53% (or US$1.82) to US$42.00 with 69.29 million shares exchanged hands, compared to daily average volume of 49.55 million. The company reaped a pre-tax windfall of US$9.5 billion by cashing out 140 million of its Alibaba shares last month, but still owns a 16% stake currently worth about US$35 million. According to Yahoo's Q3 earnings report, the company achieved its revenue growth through strong momentum in the new areas of investment: mobile, social, native and video, despite industry headwinds in some of its large legacy businesses. Insiderslab.com found company Chief Executive Officer, Marissa Ann Mayer, sold her shares at the price of US$37.77 for about US$1.36 million on October 16. Investors may want to find out how Yahoo insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for YHOO here.
Exclusive Report: http://www.insiderslab.com/PR3/102314A/YHOO/Yahoo
3D Systems Corporation (NYSE:DDD): By the end of last trading session, the shares of 3D Systems (NYSE:DDD) plunged 15.47% (or US$6.71) to US$36.67 with 15.16 million shares exchanged hands, compared to daily average volume of 2.87 million. The 3-D printing company cut its full year revenue forecasts to levels below analysts' expectations. The production issues despite high demand would hurt its full year bottom line and lowered its revenue guidance to between US$650 million and US$690 million from its previous view of between US$700 million and US$740 million. Insiderslab.com found company Chief Technology Officer, Charles W. Hull, sold his shares at the price of US$41.90 on October 20. Investors may want to find out how 3D Systems insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for DDD here.
Exclusive Report: http://www.insiderslab.com/PR3/102314A/DDD/3DSystems
Regulus Therapeutics Inc. (NASDAQ:RGLS): By the end of last trading session, the shares of Regulus Therapeutics (NASDAQ:RGLS) soared 103.10% (or US$6.98) to US$13.75 with 20.31 million shares exchanged hands, compared to daily average volume of 0.06 million. The company announced its interim result from an early-stage study that a single injection of microRNA therapeutic directed at a genetic target in the liver of hepatitis C patients produced a significant drop in viral load. Hepatitis C is an insanely crowded and competitive field, but investors see in the early Regulus RG-101 data the potential for a new way to cure the liver disease with a single or even a few simple and easily tolerate, under-the-skin injections, instead of four, eight or 12 weeks of daily pills. Insiderslab.com found company CEO, Kleanthis G. Xanthopoulos, sold his shares at the price of US$7.00 on October 20. Investors may want to find out how Regulus Therapeutics cals insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for RGLS here.
Exclusive Report: http://www.insiderslab.com/PR3/102314A/RGLS/RegulusTherapeutics
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may be involved in trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Huntington Bancshares Incorporated (NASDAQ:HBAN):
Exclusive Report: http://www.insiderslab.com/PR3/102314A/HBAN/HuntingtonBancshares
Cree, Inc. (NASDAQ:CREE):
Exclusive Report: http://www.insiderslab.com/PR3/102314A/CREE/Cree
Advanced Micro Devices, Inc. (NYSE:AMD):
Exclusive Report: http://www.insiderslab.com/PR3/102314A/AMD/AMD
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Insiderslab.com:
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/reveal-insider-trading-for-yahoo-3d-systems-regulus-therapeutics-huntington-bancshares-cree-and-amd-513173671.html
